The NanoChemBio research group of the Genomics and Oncology Research Centre (GENyO), together with the Research Results Transfer Office (OTRI) of the University of Granada (UGR), participated in the fourteenth edition of Transfiere 2025, the leading European forum on R&D&I and knowledge transfer. The event, held from 12 to 14 March in Malaga, brought together more than 5,200 professionals from the innovation ecosystem.

An innovative nanotechnology platform for the detection of exosomes

During Transfiere 2025, the NanoChemBio group presented ‘Exo-Magbeads – Validation of platform for the capture, marking and analysis of exosomes by mass cytometry’, a pioneering method that allows advanced analysis of exosomes in liquid biopsy. This technology represents an important advance in personalised medicine and in improving the diagnosis and treatment of various pathologies.

Rosario M. Sánchez, the researcher in charge of the NanoChemBio group, presented this innovative nanotechnology platform in the framework of the Elevator Pitch of the International Innovation Programme 2025, which focused on international projects in the field of health. Exo-Magbeads is designed for the selective capture, unique labelling and safe release of exosomes in liquid biopsy. This technology facilitates the analysis of exosomes by mass cytometry, which represents a significant advance in patient stratification and its applications in both research and healthcare.

The proof of concept of Exo-Magbeads (Project PDC2022-133913-I00) has been funded by the Ministry of Science and Innovation, in the framework of the “Proof of Concept” Projects Programme of the State Plan for Scientific and Technical Research and Innovation 2021-2023 (funded by MCIU/AEI /10.13039/501100011033 and by the European Union Next GenerationEU/ PRTR), under the State Programme to Promote Scientific-Technical Research and its Transfer and the State Sub-programme for Knowledge Transfer.

With its participation in Transfiere 2025, NanoChemBio reinforces its commitment to technology transfer and the promotion of innovation in the health sector, contributing to the improvement of diagnostic and treatment processes through advances in nanotechnology applied to biomedicine.

See more news